Key Takeaways
- Alveo Technologies partners with AgriNerds to enhance early avian flu detection for poultry farmers.
- The system combines real-time bird tracking with fast molecular diagnostics to reduce outbreak response time.
- Advanced risk prediction models could help limit the spread of infection and minimize culling of flocks.
Partnership for Early Detection
Rapid on-farm pathogen testing company Alveo Technologies has collaborated with AgriNerds, a specialist in wildfowl surveillance, to create an early warning system for avian influenza. This system aims to enhance poultry farmers’ ability to detect and contain outbreaks prior to significant escalation.
The partnership integrates AgriNerds’ Waterfowl Alert Network—which utilizes radar, satellite imagery, telemetry, and other data sources to identify high-risk infection areas—from wild birds, with Alveo’s portable molecular diagnostics platform that can identify avian flu in just 45 minutes. This innovative approach seeks to bridge the gap between continuous, impractical surveillance and the delayed response associated with waiting for birds to exhibit symptoms and then obtaining PCR lab results, which can take an additional two to three days.
By employing AgriNerds’ models, producers can intensify testing during times of heightened migratory bird activity or other risk-enhancing conditions. Alveo President Erik Tyrrell-Knott highlighted that current indicators of illness in poultry often leave farmers facing a tough decision on whether to impose additional biosecurity measures without concrete evidence, or wait for lab results, risking further spread of the virus.
Dynamic Risk Assessment
Wild birds are well-known carriers of bird flu, posing a significant threat to poultry farms. AgriNerds assesses waterfowl abundance near poultry facilities and classifies risk levels as low, moderate, or high. Given that various factors—like weather, crops, and water availability—change constantly, the risk associated with specific farms can fluctuate year by year.
Currently, AgriNerds sends daily risk predictions to over 1,500 farms in 25 states, covering more than 160,000 commercial poultry operations. Alerts can be customized, allowing users to receive notifications only when a farm enters high-risk zones.
Impact of Early Detection
While it is true that infected flocks may ultimately need to be culled, early detection can lead to preventive actions that reduce the risk of virus transmission. For example, restricting movements of personnel, feed trucks, and other vehicles can limit the spread. Tyrrell-Knott noted that about 30% of bird flu cases result from transmission between farms rather than directly from wild birds.
Additionally, Alveo’s testing results could enhance AgriNerds’ predictive models by providing localized data rather than relying on larger county-level information. This granular data helps understand how feather dander might spread from infected locations, thus enabling timely warnings for farms situated downstream.
With more rapid testing and improved intelligence on bird movements, the overall number of birds culled in a facility could be significantly reduced. Tyrrell-Knott envisions a future where only a portion of a flock needs to be depopulated when infection is detected early, potentially preserving a majority of the birds.
Advanced Testing Technology
Alveo’s platform employs molecular amplification technology, offering high accuracy (96-99%) compared to standard rapid tests, which can miss the virus up to 40% of the time. The portable device is small enough to be handheld, user-friendly, and cost-effective, enabling testing directly on the farm.
In the U.S., Alveo’s current testing method involves oropharyngeal swabs, with additional methods using cloacal swabs implemented internationally.
Proactive Management Strategies
The partnership aims to shift avian flu management towards proactive risk assessment rather than reactive measures after outbreaks occur. By identifying elevated risks proactively, farmers can devise strategies to mitigate threats before they escalate.
Alveo has received approval for experimental use from USDA and state veterinarians and anticipates full approval by the end of the year as the first on-farm molecular avian flu test in the U.S.
The content above is a summary. For more details, see the source article.